Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
A recent meeting was held on March 22, 2019, among the FDA, clinical scientists,
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …
Safety of approved MR contrast media for intravenous injection
VM Runge - Journal of Magnetic Resonance Imaging: An …, 2000 - Wiley Online Library
In the last 10 years, the use of intravenous contrast media in magnetic resonance (MR) has
become well‐established clinical practice. Contrast media provide critical additional …
become well‐established clinical practice. Contrast media provide critical additional …
[HTML][HTML] Imaging of brain metastases
KR Fink, JR Fink - Surgical neurology international, 2013 - ncbi.nlm.nih.gov
Imaging plays a key role in the diagnosis of central nervous system (CNS) metastasis.
Imaging is used to detect metastases in patients with known malignancies and new …
Imaging is used to detect metastases in patients with known malignancies and new …
A pathology-based substrate for target definition in radiosurgery of brain metastases
BG Baumert, I Rutten, C Dehing-Oberije… - International Journal of …, 2006 - Elsevier
Purpose: To investigate the need of a margin other than for accuracy reasons in stereotactic
radiosurgery (SRS) of brain metastases by means of histopathology. Methods and Materials …
radiosurgery (SRS) of brain metastases by means of histopathology. Methods and Materials …
Gadobenate dimeglumine (Gd-BOPTA): an overview
MA Kirchin, GP Pirovano, A Spinazzi - Investigative radiology, 1998 - journals.lww.com
NOTWITHSTANDING the discovery in the 1940s that ferric nitrate enhances the relaxation
rate of water protons, 1 it was not until 1973 that the first magnetic resonance (MR) images of …
rate of water protons, 1 it was not until 1973 that the first magnetic resonance (MR) images of …
Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging
FM CAVAGNA, F MAGGIONI, PM CASTELLI… - Investigative …, 1997 - journals.lww.com
RATIONALE AND OBJECTIVES The authors assess the effect of weak protein binding on
the efficacy of gadolinium chelates as contrast agents for magnetic resonance imaging …
the efficacy of gadolinium chelates as contrast agents for magnetic resonance imaging …
[BOOK][B] Magnetic resonance procedures: health effects and safety
FG Shellock - 2000 - taylorfrancis.com
Magnetic Resonance Procedures: Health Effects and Safety is the first authoritative text on
MR procedures and its associated health and safety concerns written by noted radiologists …
MR procedures and its associated health and safety concerns written by noted radiologists …
Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site
DW Golden, KR Lamborn, MW McDermott… - Journal of …, 2008 - thejns.org
Object The authors conducted a study to determine whether prognostic factors and the
applicability of prognostic systems vary by primary tumor site in patients treated with …
applicability of prognostic systems vary by primary tumor site in patients treated with …
[HTML][HTML] Assessment of pharmacokinetic, pharmacodynamic profile, and tolerance of gadopiclenol, a new high relaxivity GBCA, in healthy subjects and patients with …
J Hao, P Bourrinet, P Desché - Investigative Radiology, 2019 - journals.lww.com
Objectives The aim of this study was to evaluate the pharmacokinetics, safety profile, and
pharmacodynamics of gadopiclenol, a new high relaxivity macrocyclic gadolinium-based …
pharmacodynamics of gadopiclenol, a new high relaxivity macrocyclic gadolinium-based …
Dose finding study of gadopiclenol, a new macrocyclic contrast agent, in MRI of central nervous system
M Bendszus, D Roberts, B Kolumban… - Investigative …, 2020 - journals.lww.com
Objectives The aim of this study was to determine a safe and effective dose of gadopiclenol,
a new high relaxivity macrocyclic gadolinium-based contrast agent. Based on the contrast-to …
a new high relaxivity macrocyclic gadolinium-based contrast agent. Based on the contrast-to …